Cargando…

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study

Detection of p16 through immunohistochemistry (IHC) is the standard for determining the HPV status of the tumor according the TNM eighth edition released in 2017 and has become crucial for determining the HPV status of oropharyngeal squamous cell carcinomas (OPSCC) with direct impact on staging and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loermann, Gera, Kolb, Marlen, Prascevic, Dusan, Siemert, Julia, Wiegand, Susanne, Zebralla, Veit, Pirlich, Markus, Stöhr, Matthäus, Dietz, Andreas, Wald, Theresa, Wichmann, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570661/ https://www.ncbi.nlm.nih.gov/pubmed/36233378 http://dx.doi.org/10.3390/jcm11195509

Ejemplares similares

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Siemert, Julia, et al.
Publicado: (2021)

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery
por: Kunz, Viktor, et al.
Publicado: (2022)

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker
por: Berszin, Michael, et al.
Publicado: (2022)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Oropharynx HPV status and its relation to HIV infection
por: Vianna, Leonora Maciel de Souza, et al.
Publicado: (2018)

Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx
por: Castro, Therezita Peixoto Patury Galvão, et al.
Publicado: (2015)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
por: Lübbers, Katharina, et al.
Publicado: (2021)

Web-Based Patient-Reported Outcomes for ENT Patients—Evaluation of the Status Quo, Patients’ View, and Future Perspectives
por: Wald, Theresa, et al.
Publicado: (2022)

Dysphagia, voice problems, and pain in head and neck cancer patients
por: Zebralla, Veit, et al.
Publicado: (2021)

Absence of HPV Infection Is Associated with Smoker Patients with Squamous Cell Carcinoma of the Oropharynx
por: Soares, Gláucia Resende, et al.
Publicado: (2014)

Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity
por: SHIGEISHI, Hideo, et al.
Publicado: (2016)

Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer
por: Bahig, Houda, et al.
Publicado: (2020)

Dosimetric Results for Adjuvant Proton Radiation Therapy of HPV-Associated Oropharynx Cancer
por: Wright, Christopher M., et al.
Publicado: (2021)

A Radiomics-Based Machine Learning Perspective on the Parotid Gland as a Potential Surrogate Marker for HPV in Oropharyngeal Cancer
por: Prasse, Gordian, et al.
Publicado: (2023)

Predictive Value of HPV, p53, and p16 in the Post-Treatment Evolution of Malignant Tumors of the Oropharynx and Retromolar Trigone–Oropharynx Junction
por: Cobzeanu, Bogdan Mihail, et al.
Publicado: (2020)

HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland
por: Durzyńska, Julia, et al.
Publicado: (2010)

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
por: Hammermüller, C., et al.
Publicado: (2021)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV([Formula: see text]) Controls
por: Bais, Aagje G., et al.
Publicado: (2007)

Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx
por: Johnson, Luke, et al.
Publicado: (2022)

Imaging of human papilloma virus (HPV) related oropharynx tumour: what we know to date
por: Bicci, Eleonora, et al.
Publicado: (2023)

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study
por: Hall, Stephen F, et al.
Publicado: (2017)

Course of Self-Reported Dysphagia, Voice Impairment and Pain in Head and Neck Cancer Survivors
por: Zebralla, Veit, et al.
Publicado: (2021)

HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome
por: Chernock, Rebecca D., et al.
Publicado: (2009)

MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers
por: Song, Xicheng, et al.
Publicado: (2013)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

Determination and evaluation of HR-HPV genotype in different communities of Bihar, India
por: Parwez, Akhtar, et al.
Publicado: (2022)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

Impact of HR-HPV infection on oncological outcomes in early cervical cancer
por: Su, Xiaoqiang, et al.
Publicado: (2023)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients
por: Cedra, Susan, et al.
Publicado: (2017)

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
por: Junor, E, et al.
Publicado: (2012)

MDM4 genetic variants predict HPV16-positive tumors of patients with squamous cell carcinoma of the oropharynx
por: Lu, Zhongming, et al.
Publicado: (2017)

Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
por: Dombrowski, Caroline A., et al.
Publicado: (2022)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples
por: Chaiwongkot, Arkom, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76f5h5j89ns0q8dfgaf57vcprl